Literature DB >> 19056845

Genes, geography and geometry: the "critical mass" in hypertrophic cardiomyopathy.

Nina Kaludercic1, Carlo Reggiani2, Nazareno Paolocci3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19056845      PMCID： PMC2607560          DOI： 10.2353/jmoldx.2009.080138

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN： 1525-1578            Impact factor:   5.568


× No keyword cloud information.
  25 in total

1.  Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.

Authors:  H Niimura; L L Bachinski; S Sangwatanaroj; H Watkins; A E Chudley; W McKenna; A Kristinsson; R Roberts; M Sole; B J Maron; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1998-04-30       Impact factor: 91.245

2.  Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.

Authors:  Meghan J Perkins; Sara L Van Driest; Erik G Ellsworth; Melissa L Will; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Journal:  Eur Heart J       Date:  2005-08-08       Impact factor: 29.983

3.  Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.

Authors:  Mayu Nishio; Yasushi Sakata; Toshiaki Mano; Junichi Yoshida; Tomohito Ohtani; Yasuharu Takeda; Takeshi Miwa; Tohru Masuyama; Kazuhiro Yamamoto; Masatsugu Hori
Journal:  J Hypertens       Date:  2007-02       Impact factor: 4.844

4.  The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation.

Authors:  F Tesson; C Dufour; J C Moolman; L Carrier; S al-Mahdawi; L Chojnowska; O Dubourg; E Soubrier; P Brink; M Komajda; P Guicheney; K Schwartz; J Feingold
Journal:  J Mol Cell Cardiol       Date:  1997-02       Impact factor: 5.000

5.  Valsartan decreases type I collagen synthesis in patients with hypertrophic cardiomyopathy.

Authors:  Hiroaki Kawano; Genji Toda; Reiichirou Nakamizo; Yuji Koide; Shinji Seto; Katsusuke Yano
Journal:  Circ J       Date:  2005-10       Impact factor: 2.993

6.  Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

Authors:  Michael Arad; Barry J Maron; Joshua M Gorham; Walter H Johnson; J Philip Saul; Antonio R Perez-Atayde; Paolo Spirito; Gregory B Wright; Ronald J Kanter; Christine E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

7.  Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy.

Authors:  Aloir Queiroz Araujo; Edmundo Arteaga; Barbara Maria Ianni; Paula Cassia Buck; Rogerio Rabello; Charles Mady
Journal:  Am J Cardiol       Date:  2005-10-11       Impact factor: 2.778

8.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.

Authors:  B J Maron; J Shirani; L C Poliac; R Mathenge; W C Roberts; F O Mueller
Journal:  JAMA       Date:  1996-07-17       Impact factor: 56.272

9.  A new therapeutic strategy for hypertrophic nonobstructive cardiomyopathy in humans. A randomized and prospective study with an Angiotensin II receptor blocker.

Authors:  Tadashi Yamazaki; Jun-Ichi Suzuki; Ryoichi Shimamoto; Taeko Tsuji; Yuki Ohmoto-Sekine; Kuni Ohtomo; Ryozo Nagai
Journal:  Int Heart J       Date:  2007-11       Impact factor: 1.862

10.  Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.

Authors:  Ali J Marian; Vinitha Senthil; Suet N Chen; Raffaella Lombardi
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094
View more
  1 in total

1.  Survival and clinical behavior of hypertrophic cardiomyopathy in a latin american cohort in contrast to cohorts from the developed world.

Authors:  Nilda Espinola-Zavaleta; Antonio Vega; Diego Martínez Basto; Ana Cecilia Alcantar-Fernández; Veronica Guarner Lans; María Elena Soto
Journal:  J Cardiovasc Ultrasound       Date:  2015-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.